{
  "ticker": "LLY",
  "target_date": "2025-01-20",
  "actual_date": "2025-01-17",
  "collected_at": "2025-12-08T11:17:50.084319",
  "price": {
    "open": 742.29,
    "high": 749.69,
    "low": 719.64,
    "close": 720.3470458984375,
    "volume": 5560100,
    "change_1d_pct": -4.21,
    "change_7d_pct": -6.15,
    "change_30d_pct": -10.77
  },
  "technicals": {
    "rsi_14": 31.34,
    "sma_20": 767.43,
    "sma_50": 776.59,
    "macd": -11.281,
    "macd_signal": -7.396,
    "macd_histogram": -3.885,
    "bb_upper": 807.1,
    "bb_lower": 727.76,
    "price_vs_sma20_pct": -6.14,
    "price_vs_sma50_pct": -7.24,
    "volume_ratio": 1.45
  },
  "fundamentals": {
    "market_cap": 889504858112,
    "pe_ratio": 48.615635,
    "forward_pe": 43.7884,
    "price_to_book": 37.358627,
    "price_to_sales": 14.969839,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.77,
    "pct_from_52w_low": 59.07
  },
  "macro": {
    "spy": {
      "price": 592.39,
      "change_1d_pct": 1.0,
      "change_7d_pct": 1.37
    },
    "vix": {
      "level": 15.97,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.61
    },
    "dollar_index": {
      "level": 109.35
    },
    "gold": {
      "price": 2744.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Viking Therapeutics: The Turning Point Is Not Here Yet",
      "source": "SeekingAlpha",
      "datetime": 1737383698,
      "summary": "Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma remains risky.",
      "url": "https://finnhub.io/api/news?id=13352d11da720b6f820b3d891efe5ba459d5c223aa5daaf2ec4bd3b9bb12ead0"
    },
    {
      "headline": "Carillon ClariVest Capital Appreciation Fund Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1737373020,
      "summary": "At the start of the quarter, Carillon ClariVest Capital Appreciation Fund vs. Russell 1000 Growth Index, was most overweight the healthcare and financials sectors.",
      "url": "https://finnhub.io/api/news?id=54cf828d9caeaafcb426d9422ac96510c78190fca07684df97dbf1bdbb80c73c"
    },
    {
      "headline": "ClearBridge Appreciation ESG Strategy Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1737359700,
      "summary": "The ClearBridge Appreciation ESG Strategy outperformed the benchmark S&P 500 Index in the fourth quarter of 2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=d0b43507d72a706c01efba5d99d3bb9d5b02d85ccda8e897b48dce6f06529f28"
    },
    {
      "headline": "IYH: Healthcare Dashboard For January",
      "source": "SeekingAlpha",
      "datetime": 1737351767,
      "summary": "iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.",
      "url": "https://finnhub.io/api/news?id=86abfb300be5fe18fd5f0ffd4e4f143d62a99946668de83db5584543560aa5e1"
    },
    {
      "headline": "Top 4 Immunology Stocks Poised For Growth In 2025",
      "source": "SeekingAlpha",
      "datetime": 1737305685,
      "summary": "Discover the latest trends and developments in the global immunology drugs market, along with four promising stocks to watch for potential investments.",
      "url": "https://finnhub.io/api/news?id=89d92fb4873b2558c4d0f5f75610a8a4ee6050f99c0d8d2410f07380589e1d07"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-01-14",
      "description": "lly-20250114.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000005/lly-20250114.htm"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470584.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/xslF345X05/wk-form4_1734470584.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470498.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/xslF345X05/wk-form4_1734470498.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470366.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/xslF345X05/wk-form4_1734470366.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470270.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/xslF345X05/wk-form4_1734470270.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}